SHF Svendborg Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2001
NCT00124397
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Department of Medical Research, SHF Svendborg

Active Ingredients

Drugs in Phase 4 Trials (2)

atorvastatin (lipitor) (1 trial)

irbesartan (avapro) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2